about
Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies.Guidelines for the diagnosis and treatment of cobalamin and folate disorders.Clinical guidelines for testing for heritable thrombophilia.Effects on routine coagulation screens and assessment of anticoagulant intensity in patients taking oral dabigatran or rivaroxaban: guidance from the British Committee for Standards in Haematology.Guidelines on oral anticoagulation (warfarin): third edition--2005 update.Guidelines on the management of acute myeloid leukaemia in adults.Guidelines for the management of anticoagulant and antiplatelet therapy in patients undergoing endoscopic procedures.Guidelines for the diagnosis and management of aplastic anaemia.Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma).Guideline on the investigation, management and prevention of venous thrombosis in children.Guidelines on the investigation and management of antiphospholipid syndrome.Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis.Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutations.Management of cytomegalovirus infection in haemopoietic stem cell transplantation.Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. British Committee for Standards in Haematology.Guidelines for the laboratory investigation of heritable disorders of platelet function.Guideline on aspects of cancer-related venous thrombosis.A practical guideline for the haematological management of major haemorrhage.Guidelines on the management and admission to intensive care of critically ill adult patients with haematological malignancy in the UK.Guidelines on the management of anaemia and red cell transfusion in adult critically ill patients.Guidelines on red cell transfusion in sickle cell disease. Part I: principles and laboratory aspects.Guideline for blood grouping and red cell antibody testing in pregnancy.UK guidelines on the management of iron deficiency in pregnancy.Amendment to the guideline for diagnosis and investigation of polycythaemia/erythrocytosis.Guideline for the laboratory diagnosis of functional iron deficiency.Obtaining consent for chemotherapy.Bone marrow assessment in asymptomatic IgM monoclonal gammopathies - reply to Varettoni et al.Guidelines on the diagnosis and management of Waldenström macroglobulinaemia.Guidelines on the diagnosis and management of multiple myeloma 2005.Guidelines on the use of multicolour flow cytometry in the diagnosis of haematological neoplasms. British Committee for Standards in Haematology.Guidelines on transfusion for fetuses, neonates and older children.Guidelines for the diagnosis and management of adult myelodysplastic syndromes.Guidelines for the management of diffuse large B-cell lymphoma.Guideline for the investigation and management of eosinophilia.
P50
Q33401403-2A827D99-018C-4CB3-B1B4-6BF03B507A5DQ34041279-69AAB58A-CEF6-4209-9489-364C4C42B825Q34096556-A9EEA558-5377-47A1-8134-C5A8B447D9E2Q34299226-36F0F654-A930-420D-9D21-983C577615D8Q34484090-1BB7BA89-EB84-4571-BE58-531983F737F2Q36630107-56DDF4F7-D505-4254-93BE-F23A591A6ABDQ37158882-3FD2845A-3F8F-43F6-B48B-ACBD5114551CQ37578630-770A5245-DEB8-4677-B118-4CF2152DE857Q37863688-AECD9F5F-C039-4154-8BB3-E27DD6393721Q37877279-2110E9CE-17A6-4792-A39E-1F934DE051FAQ37982121-5CE9B40D-E023-4E5C-92E8-560EC01AB32FQ38043534-80456F33-6B19-47DB-9C4E-C3A5FC437B81Q43979129-3A332C65-082A-456A-A804-6D1BCB3220B1Q44714539-FA32CBC3-D562-4C78-9A36-5E9F5698FD42Q45141633-08D6F51D-E5A9-4FF4-A75A-63AD2F8A1A20Q45872104-7EE67012-58B8-441F-9285-B5F190B01BE2Q45877193-5B952C5B-4413-46AF-B6E7-8F313152C695Q45877402-CA419180-B6EB-4CDA-9D04-544AF6005168Q47569744-4D66EF34-733D-4612-8D3A-7AB737031577Q48231014-06670779-6887-4B15-8F53-E883CD3F79D6Q50218898-AF9270B0-1EC0-4F36-9194-1D22B7DCEAF2Q50244580-79D08703-BB86-4815-9250-E3BC5A0056ACQ50512929-BEDCDB69-F7C0-4528-8966-57EF22F1AEF1Q50671166-7CFC8AFA-191B-48F2-BA92-BBB2915F816EQ51076582-83C35771-88B8-4C2D-843D-BCD4D92D4F84Q51921846-250FFB11-414D-4E2C-9781-4A57FA2292F6Q52839019-29D906AE-282D-4551-800D-618C6CB9BC0FQ52840250-9A6DBE6F-7EB2-4806-BB15-01395C3B34F6Q53556535-BB3CA8DC-4CF7-4CA8-B9F6-312C0531CC7DQ53600589-2F099CA6-6BF9-43C2-93B9-36A8F89BF6A8Q53674609-6C230C84-3EA8-4133-A70B-1557E061B2E7Q54392826-900E53CC-A433-4D45-9C5E-0BEE3F18BDCBQ54708579-8F6981DD-D113-4D6E-BBE1-DE4FA714FA92Q55059996-C2435E5A-D261-4F90-94FB-462DC61EB271
P50
name
British Committee for Standards in Haematology
@en
type
label
British Committee for Standards in Haematology
@en
prefLabel
British Committee for Standards in Haematology
@en
P214
P214
P31
P7859
lccn-n92800155